LB Pharmaceuticals
LB Pharmaceuticals is a development stage life sciences company devoted to commercializing novel and improved versions of successful CNS treatments used extensively overseas but never developed, approved, or marketed in the United States. Its approach is to create a research-focused organization dedicated to generating novel intellectual property around improved versions of these former best-selling drugs. The Company's lead asset is LB-102 (n-Methyl amisulpride) a novel, patented version of amisulpride, one of the most effective drugs ever developed for the treatment of schizophrenia.
Tech Stack (15 technologies)
Frequently Asked Questions
What technologies does LB Pharmaceuticals use?+
LB Pharmaceuticals uses 15 technologies including Contact Form 7, WordPress, Matomo Analytics.
What industry is LB Pharmaceuticals in?+
LB Pharmaceuticals operates in the Biopharma industry.
Where is LB Pharmaceuticals based?+
LB Pharmaceuticals is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026